Association of Serum Periostin Level with Classical Bone Turnover Markers and Bone Mineral Density in Shanghai Chinese Postmenopausal Women with Osteoporosis

References

• Lorentzon M, Cummings SR. Osteoporosis: the evolution of a diagnosis. J Intern Med. 2015;277(6):650–661. doi:10.1111/joim.12369
   PubMed Web of Science ®Google Scholar
• Youness ER, Mohammed NA, Morsy FA. Cadmium impact and osteoporosis: mechanism of action. Toxicol Mech Methods. 2012;22(7):560–567. doi:10.3109/15376516.2012.702796
   PubMed Web of Science ®Google Scholar
• Alswat KA. Gender disparities in osteoporosis. J Clin Med Res. 2017;9(5):382–387. doi:10.14740/jocmr2970w
   PubMedGoogle Scholar
• Hernlund E, Svedbom A, Ivergård M, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1–2):136. doi:10.1007/s11657-013-0136-1
   PubMed Web of Science ®Google Scholar
• Maggi S, Noale M, Giannini S, et al. Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study. Osteoporos Int. 2006;17(2):237–244. doi:10.1007/s00198-005-1985-2
   PubMed Web of Science ®Google Scholar
• Cui Z, Meng X, Feng H, et al. Estimation and projection about the standardized prevalence of osteoporosis in mainland China. Arch Osteoporos. 2019;15(1):2. doi:10.1007/s11657-019-0670-6
   PubMed Web of Science ®Google Scholar
• Kanis JA.Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368–381. doi:10.1007/BF01622200
   Google Scholar
• Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164(10):1108–1112. doi:10.1001/archinte.164.10.1108
   PubMedGoogle Scholar
• Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34(1):195–202. doi:10.1016/j.bone.2003.10.001
   PubMed Web of Science ®Google Scholar
• Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005;26(4):97–122.
   PubMedGoogle Scholar
• Vasikaran S, Eastell R, Bruyère O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391–420. doi:10.1007/s00198-010-1501-1
   PubMed Web of Science ®Google Scholar
• Chopin F, Biver E, Funck-Brentano T, et al. Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis. Joint Bone Spine. 2012;79(1):26–31. doi:10.1016/j.jbspin.2011.05.004
   PubMed Web of Science ®Google Scholar
• Szulc P, Garnero P, Marchand F, Duboeuf F, Delmas PD. Biochemical markers of bone formation reflect endosteal bone loss in elderly men–MINOS study. Bone. 2005;36(1):13–21. doi:10.1016/j.bone.2004.09.004
   PubMed Web of Science ®Google Scholar
• Seeman E. The periosteum–a surface for all seasons. Osteoporos Int. 2007;18(2):123–128. doi:10.1007/s00198-006-0296-6
   PubMed Web of Science ®Google Scholar
• Bonnet N, Garnero P, Ferrari S. Periostin action in bone. Mol Cell Endocrinol. 2016;432:75–82. doi:10.1016/j.mce.2015.12.014
   PubMed Web of Science ®Google Scholar
• Garnero P. New developments in biological markers of bone metabolism in osteoporosis. Bone. 2014;66:46–55. doi:10.1016/j.bone.2014.05.016
   PubMed Web of Science ®Google Scholar
• Contié S, Voorzanger-Rousselot N, Litvin J, et al. Development of a new ELISA for serum periostin: evaluation of growth-related changes and bisphosphonate treatment in mice. Calcif Tissue Int. 2010;87(4):341–350. doi:10.1007/s00223-010-9391-y
   PubMed Web of Science ®Google Scholar
• Anastasilakis AD, Polyzos SA, Makras P, et al. Circulating periostin levels do not differ between postmenopausal women with normal and low bone mass and are not affected by zoledronic acid treatment. Horm Metab Res. 2014;46(2):145–149.
   PubMed Web of Science ®Google Scholar
• Rousseau JC, Sornay-Rendu E, Bertholon C, Chapurlat R, Garnero P. Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study. J Clin Endocrinol Metab. 2014;99(7):2533–2539. doi:10.1210/jc.2013-3893
   PubMed Web of Science ®Google Scholar
• Kim BJ, Rhee Y, Kim CH, et al. Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: clinical evidence for the different effects of periostin depending on the skeletal site. Bone. 2015;81:435–441. doi:10.1016/j.bone.2015.08.014
   PubMed Web of Science ®Google Scholar
• Farrokhi M, Arjaki D, Peykanpour F. Circulating periostin levels increase in association with bone density loss and healing progression during the early phase of hip fracture in Chinese older women. Osteoporos Int. 2020;31(10):2061. doi:10.1007/s00198-020-05606-7
   PubMed Web of Science ®Google Scholar
• Merle B, Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int. 2012;23(4):1199–1212. doi:10.1007/s00198-011-1892-7
   PubMed Web of Science ®Google Scholar
• Heo SC, Shin WC, Lee MJ, et al. Periostin accelerates bone healing mediated by human mesenchymal stem cell-embedded hydroxyapatite/tricalcium phosphate scaffold. PLoS One. 2015;10(3):e0116698. doi:10.1371/journal.pone.0116698
   PubMed Web of Science ®Google Scholar
• Horiuchi K, Amizuka N, Takeshita S, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14(7):1239–1249. doi:10.1359/jbmr.1999.14.7.1239
   PubMed Web of Science ®Google Scholar
• Li C, Li X, Wang X, et al. Periostin mediates oestrogen-induced osteogenic differentiation of bone marrow stromal cells in ovariectomised rats. Biomed Res Int. 2020;2020:9405909.
   PubMed Web of Science ®Google Scholar
• Chung KW, Kim MR, Yoo SW, et al. Can bone turnover markers correlate bone mass at the hip and spine according to menopausal period? Arch Gynecol Obstet. 2000;264(3):119–123. doi:10.1007/s004040000093
   PubMed Web of Science ®Google Scholar
• Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11(3):337–349. doi:10.1002/jbmr.5650110307
   PubMed Web of Science ®Google Scholar
• Ghimire S, Miramini S, Edwards G, et al. The investigation of bone fracture healing under intramembranous and endochondral ossification. Bone Rep. 2021;14:100740. doi:10.1016/j.bonr.2020.100740
   PubMedGoogle Scholar
• Gossiel F, Scott JR, Paggiosi MA, et al. Effect of teriparatide treatment on circulating periostin and its relationship to regulators of bone formation and BMD in postmenopausal women with osteoporosis. J Clin Endocrinol Metab. 2018;103(4):1302–1309. doi:10.1210/jc.2017-00283
   PubMed Web of Science ®Google Scholar